FutureFuel Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FF research report →
Price Chart
About the company
Operating through its subsidiary, FutureFuel Chemical Company, FutureFuel Corp. manufactures and distributes a broad spectrum of chemical products across the United States, encompassing both bio-based fuels and specialized bio-based chemicals. The enterprise is structured into two principal business segments: Chemicals and Biofuels.
- CEO
- Roeland H. Polet
- IPO
- 2011
- Employees
- 493
- HQ
- Batesville, AR, US
Get TickerSpark's AI analysis on FF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $224.58M
- P/E
- -7.31
- PEG
- 0.15
- P/S
- 1.47
- P/B
- 1.47
- EV/EBITDA
- -8.38
- Div Yield
- 2.73%
- Gross Margin
- -3.85%
- Op Margin
- -13.56%
- Net Margin
- -19.94%
- ROE
- -19.75%
- ROIC
- -11.15%
Latest fiscal year · YoY change
- Revenue
- $95.74M-60.7%
- Gross Profit
- $-40,689,000-307.1%
- Op Income
- $-54,254,000
- Net Income
- $-49,397,000-418.6%
- EPS
- $-1.13-422.9%
- OCF Growth
- -215.9%
- FCF Growth
- -553.7%
- 52W High
- $6.99
- 52W Low
- $3.09
- 50D MA
- $5.30
- 200D MA
- $4.37
- Beta
- 0.97
- RSI (14)
- 45
- Avg Volume
- 411.19K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
FutureFuel reported a sharp Q2 turnaround to profit, driven by higher volumes, better plant utilization, and improved biofuels economics, while management said it remains on pace for positive adjusted EBITDA in 2026.· August 11, 2026
- Revenue rose to $78.7 million from $35.7 million a year ago, with total volume up 40.4% and average blended price up 80.2%.
- Gross profit improved to $15.0 million from a $12.4 million gross loss; net income was $11.4 million versus a $14.2 million net loss last year.
- Chemicals gross profit increased to $5.0 million from $1.1 million, while biofuels gross profit swung to $10.1 million from a $13.5 million gross loss.
- Management said total production increased 26% year over year and that both segments generated positive gross profit per unit sold.
- The company reiterated it is on pace to deliver positive adjusted EBITDA for full-year 2026 and highlighted a new 4-year credit monetization agreement tied to 45Z and small producer tax credits.
Total revenue was $78.7 million in the second quarter of 2024, up 120.7% from $35.7 million in the second quarter of 2023. Total gross profit was $15.0 million versus a gross loss of $12.4 million a year ago, net income was $11.4 million versus a net loss of $14.2 million, and adjusted EBITDA was $11.8 million versus a loss of $11.4 million. Total volume growth was 40.4% and average blended price increased 80.2%. Chemicals segment revenue increased to $25.8 million from $16.6 million, with Chemicals gross profit of $5.0 million versus $1.1 million last year. Biofuel segment revenue increased to $52.9 million from $19.1 million, with Biofuel gross profit of $10.1 million versus a $13.5 million gross loss. Management said it remains on pace to deliver positive adjusted EBITDA for full-year 2026. Rose Sparks said cash and cash equivalents were $34.3 million at June 30, 2026, up from $22.4 million at March 31, 2026, with a $35 million revolver and no borrowings. She also said the company expects $22 million of gross proceeds from credit monetization in the second half of 2024, including about $3 million in Q3 and $19 million in Q4.
Roeland Polet used the call to reintroduce the company’s strategy: leverage the Batesville complex as an integrated, hard-to-replicate platform for specialty chemicals and biodiesel, and focus on profitable growth, operational excellence, and disciplined capital allocation. He said the business is moving past reliability and regulatory headwinds, and framed the quarter as evidence of improving utilization and stronger end-market demand. His tone was confident but still measured, emphasizing that further plant and efficiency work remains ahead.
Rose Sparks focused on the financial inflection point in the quarter: revenue of $78.7 million, gross profit of $15.0 million, net income of $11.4 million, and adjusted EBITDA of $11.8 million. She highlighted the drivers behind the improvement, including higher throughput, better price realization, and the reversal of prior hedging impacts, while noting chemicals capacity utilization improved to 65% and biofuel utilization to 56%. On liquidity, she cited $34.3 million of cash, a $35 million revolver with no borrowings, $8.0 million of Q2 capex, and the expected $22 million of gross credit-monetization proceeds in the second half of 2024.
Analysts focused on how far along the plant-reliability improvement cycle is, how the 45Z monetization works, and what gives FutureFuel an edge in complex chemical manufacturing. Polet said Batesville is roughly 60% to 70% through the most important infrastructure work and that the next phase is efficiency-focused investment. On 45Z, Sparks said the company expects annual monetization tied to production, with about $3 million in Q3 and $19 million in Q4 this year. Management also said customer buildouts often take 1.5 to 2 years to ramp, but once commercialized they are sticky and can run for years.
The quarter showed a clear operational and financial rebound, with revenue, gross profit, net income, and adjusted EBITDA all moving materially higher year over year. Management also described a healthy pipeline of customer projects, improving plant utilization, and a more favorable biofuels regulatory backdrop, while saying it remains on pace for positive adjusted EBITDA in 2026.
Management still flagged elevated raw material costs, especially soybean oil, as a near-term headwind in biofuels. Polet said further plant and efficiency work is still needed, and customer projects have long lead times of roughly 1.5 to 2 years before they convert into production, so the benefits will not all show up immediately.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 59.3%
- Shares Outstanding
- 43.86M
- Float Shares
- 26.03M
of shares held by institutions
102 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for FF, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 1.91M | ▲ 82.52K |
| Renaissance Technologies LLC | 1.43M | ▼ 144.30K |
| Vanguard Group Inc | 1.43M | ▲ 20.49K |
| Dimensional Fund Advisors LP | 1.43M | ▼ 258.49K |
| Ameriprise Financial Inc | 1.32M | ▲ 1.21M |
| Vanguard Capital Management LLC | 1.14M | ▼ 24.23K |
| Two Sigma Investments, LP | 782.08K | ▼ 46.00K |
| Geode Capital Management, LLC | 660.89K | ▼ 1.73K |
| State Street Corp | 620.42K | ▼ 915 |
| Citadel Advisors LLC | 540.99K | ▲ 154.34K |
| Bridgeway Capital Management, LLC | 473.29K | ▼ 5.13K |
| Aqr Capital Management LLC | 433.13K | ▲ 276.91K |
Held by 111 ETFs
Biggest fund positions in FF by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 4, 26 | Polet Roeland | buy | 10,000 |
| Mar 18, 26 | KRUSZEWSKI RONALD J | other | 10,000 |
| Mar 18, 26 | Rowe Richard P. | other | 10,000 |
| Mar 18, 26 | Manheim Paul | other | 10,000 |
| Mar 18, 26 | Butcher Pamela R | other | 10,000 |
| Mar 18, 26 | Novelly Paul Anthony II | other | 10,000 |
| Mar 18, 26 | Greer GBruce | other | 10,000 |
| Mar 18, 26 | Bedell Donald C. | other | 10,000 |
| Mar 18, 26 | COLE DALE E | other | 10,000 |
| Dec 11, 25 | SPARKS ROSE | other | 5,012 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our FF coverage
Recent articles, reports, and earnings notes.
No research on FF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FF report →Faraday Future Founder and Global CEO YT Jia Weekly Investor Update: Sales and Shipments of FF EAI Robotics Devices Reached 265 Units in September, Setting a New Monthly Record
gurufocus.com · Oct 5
Faraday Future Showcases its EAI Robotics World 2.0 at IROS 2026; Its Four-Core Full-Stack AI Ecosystem and Industry Productivity Solutions Receives Positive Industry Response as the Company Actively
gurufocus.com · Oct 1
Faraday Future Founder and Global CEO YT Jia Weekly Investor Update: Shares Details from FF's 919 FF EAI Robotics “Four-Core Full-Stack AI” Ecosystem New Product Series Launch; Four Industry Productiv
gurufocus.com · Sep 20
Faraday Future Launches Four Industry Productivity Solutions, Nine New EAI Devices at Its 919 Event, Building Its “One-Brain Multi-Form Multi-Capability” FF EAI Robot World 2.0; All-New Futurist Now o
gurufocus.com · Sep 19
Faraday Future Enters into Amendments with Existing Investor to Reduce $5 Million Outstanding Convertible Notes Obligations
gurufocus.com · Sep 18
First Mining Announces $50 Million Bought-Deal Offering of Common Shares
globenewswire.com · Sep 17
Faraday Future Continues to Strengthen Its Balance Sheet and Reduce Liability, Increasing Stockholders' Equity by Approx. $20 Million; FF's EAI Robot Cumulative Yearly Sales and Shipments Have Reached
gurufocus.com · Sep 17
Faraday Future to Unveil Nine New AI-Powered Robots and Four Industry Solutions at Its Annual 919 Launch Event, Completing Its "One-Brain Multi-Form Multi-Capability" Robot World 2.0
gurufocus.com · Sep 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.